These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 17689341)

  • 41. Preventing transitions to injecting amongst young people: what is the role of Needle and Syringe Programmes?
    Brener L; Spooner C; Treloar C
    Int J Drug Policy; 2010 May; 21(3):160-4. PubMed ID: 19427187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada.
    Cruz MF; Patra J; Fischer B; Rehm J; Kalousek K
    Int J Drug Policy; 2007 Jan; 18(1):54-61. PubMed ID: 17689344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is groin injecting an ethical boundary for harm reduction?
    Miller PG; Lintzeris N; Forzisi L
    Int J Drug Policy; 2008 Dec; 19(6):486-91. PubMed ID: 18024001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study.
    Small W; Wood E; Lloyd-Smith E; Tyndall M; Kerr T
    Drug Alcohol Depend; 2008 Nov; 98(1-2):159-62. PubMed ID: 18650034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of drug treatment for heroin sniffers: a protective factor against moving to injection?
    Kelley MS; Chitwood DD
    Soc Sci Med; 2004 May; 58(10):2083-92. PubMed ID: 15020021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Injecting-related injury and disease among clients of a supervised injecting facility.
    Salmon AM; Dwyer R; Jauncey M; van Beek I; Topp L; Maher L
    Drug Alcohol Depend; 2009 Apr; 101(1-2):132-6. PubMed ID: 19167171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study.
    Chayama KL; Ng C; Fleming T; Small W; Sue KL; McNeil R
    Harm Reduct J; 2023 Sep; 20(1):126. PubMed ID: 37679789
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Killing time with enjoyment: a qualitative study of initiation into injecting drug use in north-east India.
    Kermode M; Longleng V; Singh BC; Bowen K; Rintoul A
    Subst Use Misuse; 2009; 44(8):1070-89. PubMed ID: 19544149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk environments and drug harms: a social science for harm reduction approach.
    Rhodes T
    Int J Drug Policy; 2009 May; 20(3):193-201. PubMed ID: 19147339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The fine line between harm reduction and harm production--development of a clinical policy on femoral (groin) injecting.
    Zador D; Lintzeris N; van der Waal R; Miller P; Metrebian N; Strang J
    Eur Addict Res; 2008; 14(4):213-8. PubMed ID: 18583919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crack-heroin speedball injection and its implications for vein care: qualitative study.
    Rhodes T; Briggs D; Kimber J; Jones S; Holloway G
    Addiction; 2007 Nov; 102(11):1782-90. PubMed ID: 17784900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 'There is no profile it is just everyone': the challenge of targeting hepatitis C education and prevention messages to the diversity of current and future injecting drug users.
    Ellard J
    Int J Drug Policy; 2007 May; 18(3):225-34. PubMed ID: 17689369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of supervised injection facilities and injection risk behaviours among young drug injectors.
    Bravo MJ; Royuela L; De la Fuente L; Brugal MT; Barrio G; Domingo-Salvany A;
    Addiction; 2009 Apr; 104(4):614-9. PubMed ID: 19215603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparing injecting and non-injecting illicit opioid users in a multisite Canadian sample (OPICAN Cohort).
    Fischer B; Manzoni P; Rehm J
    Eur Addict Res; 2006; 12(4):230-9. PubMed ID: 16968998
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Barriers to accessing generic health and social care services: a qualitative study of injecting drug users.
    Neale J; Tompkins C; Sheard L
    Health Soc Care Community; 2008 Mar; 16(2):147-54. PubMed ID: 18290980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Threat or opportunity? Secondary exchange in a setting with widespread availability of needles.
    Lenton S; Bevan J; Lamond T
    Subst Use Misuse; 2006; 41(6-7):845-64. PubMed ID: 16809175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: a qualitative study.
    Cooper H; Moore L; Gruskin S; Krieger N
    Soc Sci Med; 2005 Aug; 61(3):673-84. PubMed ID: 15899325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incorporating geographic settings into a social network analysis of injection drug use and bloodborne pathogen prevalence.
    Wylie JL; Shah L; Jolly A
    Health Place; 2007 Sep; 13(3):617-28. PubMed ID: 17074527
    [TBL] [Abstract][Full Text] [Related]  

  • 59. More free syringes, fewer drug injectors in the case of Spain.
    Bravo MJ; Royuela L; Barrio G; de la Fuente L; Suarez M; Teresa Brugal M
    Soc Sci Med; 2007 Oct; 65(8):1773-8. PubMed ID: 17658207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fools rush in where angels fear to tread Playing God with Vancouver's Supervised Injection Facility in the political borderland.
    Small D
    Int J Drug Policy; 2007 Jan; 18(1):18-26. PubMed ID: 17689340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.